Your browser doesn't support javascript.
loading
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
Signori, Alessio; Izquierdo, Guillermo; Lugaresi, Alessandra; Hupperts, Raymond; Grand'Maison, Francois; Sola, Patrizia; Horakova, Dana; Havrdova, Eva; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Boz, Cavit; Grammond, Pierre; Terzi, Murat; Singhal, Bhim; Alroughani, Raed; Petersen, Thor; Ramo, Cristina; Oreja-Guevara, Celia; Spitaleri, Daniele; Shaygannejad, Vahid; Butzkueven, Helmut; Kalincik, Tomas; Jokubaitis, Vilija; Slee, Mark; Fernandez Bolaños, Ricardo; Sanchez-Menoyo, Jose Luis; Pucci, Eugenio; Granella, Franco; Lechner-Scott, Jeannette; Iuliano, Gerardo; Hughes, Stella; Bergamaschi, Roberto; Taylor, Bruce; Verheul, Freek; Edite Rio, Maria; Amato, Maria Pia; Sajedi, Seyed Aidin; Majdinasab, Nastaran; Van Pesch, Vincent; Sormani, Maria Pia; Trojano, Maria.
Afiliación
  • Signori A; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, Genova, Italy.
  • Izquierdo G; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Lugaresi A; Department of Biomedical and Neuromotor Sciences(DIBINEM), Alma Mater Studiorum, University of Bologna, Italy/IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Hupperts R; Zuyderland Ziekenhuis, Sittard, The Netherlands.
  • Grand'Maison F; Clinique Neuro Rive-Sud, Greenfield Park, QC, Canada.
  • Sola P; Nuovo Ospedale Civile S. Agostino-Estense, Modena, Italy.
  • Horakova D; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Havrdova E; Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Prat A; Hôpital Notre-Dame, Montreal, QC, Canada.
  • Girard M; Hôpital Notre-Dame, Montreal, QC, Canada.
  • Duquette P; Hôpital Notre-Dame, Montreal, QC, Canada.
  • Boz C; KTU Medical Faculty Farabi Hospital, Trabzon, Turkey.
  • Grammond P; Centre de Réadaptation En Déficience Physique Chaudière-Appalache, Levis, QC, Canada.
  • Terzi M; Medical Faculty, Ondokuz Mayis University, Samsun, Turkey.
  • Singhal B; Bombay Hospital Institute of Medical Sciences (BHIMS), Mumbai, India.
  • Alroughani R; Amiri Hospital, Kuwait City, Kuwait.
  • Petersen T; Kommunehospitalet, Aarhus, Denmark.
  • Ramo C; Hospital Germans Trias i Pujol, Badalona, Spain.
  • Oreja-Guevara C; Hospital Clinico San Carlos, Madrid, Spain.
  • Spitaleri D; Azienda Ospedaliera di Rilievo Nazionale, San Giuseppe Moscati, Avellino, Italy.
  • Shaygannejad V; Isfahan University of Medical Sciences, Isfahan, Iran.
  • Butzkueven H; Box Hill Hospital, Melbourne, VIC, Australia/Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
  • Kalincik T; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
  • Jokubaitis V; Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia.
  • Slee M; Flinders University and Medical Centre, Adelaide, SA, Australia.
  • Fernandez Bolaños R; Hospital Universitario Virgen de Valme, Seville, Spain.
  • Sanchez-Menoyo JL; Hospital de Galdakao-Usansolo, Galdakao, Spain.
  • Pucci E; UOC Neurologia, Azienda Sanitaria Unica Regionale Marche, Macerata, Italy.
  • Granella F; University of Parma, Parma, Italy.
  • Lechner-Scott J; Hunter Medical Research Institute, The University of Newcastle, Newcastle, NSW, Australia.
  • Iuliano G; Ospedali Riuniti di Salerno, Salerno, Italy.
  • Hughes S; Craigavon Area Hospital, Craigavon, UK.
  • Bergamaschi R; C. Mondino National Neurological Institute, Pavia, Italy.
  • Taylor B; Royal Hobart Hospital, Hobart, TAS, Australia.
  • Verheul F; Groene Hart Ziekenhuis, Gouda, The Netherlands.
  • Edite Rio M; Hospital São João, Porto, Portugal.
  • Amato MP; Department NEUROFARBA, Section Neuroscience, University of Florence, Florence, Italy.
  • Sajedi SA; Department of Neurology, Golestan University of Medical Sciences, Gorgan, Iran/Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Majdinasab N; Golestan Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Van Pesch V; Cliniques Universitaires Saint-Luc, Brussels, Belgium.
  • Sormani MP; Department of Health Sciences (DISSAL), Section of Biostatistics, University of Genoa, Genova, Italy.
  • Trojano M; Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy.
Mult Scler ; 24(5): 642-652, 2018 04.
Article en En | MEDLINE | ID: mdl-28382837
ABSTRACT

BACKGROUND:

Several natural history studies on primary progressive multiple sclerosis (PPMS) patients detected a consistent heterogeneity in the rate of disability accumulation.

OBJECTIVES:

To identify subgroups of PPMS patients with similar longitudinal trajectories of Expanded Disability Status Scale (EDSS) over time.

METHODS:

All PPMS patients collected within the MSBase registry, who had their first EDSS assessment within 5 years from onset, were included in the analysis. Longitudinal EDSS scores were modeled by a latent class mixed model (LCMM), using a nonlinear function of time from onset. LCMM is an advanced statistical approach that models heterogeneity between patients by classifying them into unobserved groups showing similar characteristics.

RESULTS:

A total of 853 PPMS (51.7% females) from 24 countries with a mean age at onset of 42.4 years (standard deviation (SD) 10.8 years), a median baseline EDSS of 4 (interquartile range (IQR) 2.5-5.5), and 2.4 years of disease duration (SD 1.5 years) were included. LCMM detected three different subgroups of patients with a mild ( n = 143; 16.8%), moderate ( n = 378; 44.3%), or severe ( n = 332; 38.9%) disability trajectory. The probability of reaching EDSS 6 at 10 years was 0%, 46.4%, and 81.9% respectively.

CONCLUSION:

Applying an LCMM modeling approach to long-term EDSS data, it is possible to identify groups of PPMS patients with different prognosis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Progresión de la Enfermedad / Esclerosis Múltiple Crónica Progresiva / Evaluación de la Discapacidad / Análisis de Clases Latentes Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Progresión de la Enfermedad / Esclerosis Múltiple Crónica Progresiva / Evaluación de la Discapacidad / Análisis de Clases Latentes Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia